These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27408930)

  • 61. Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy.
    Uhm JH; Dooley NP; Stuve O; Francis GS; Duquette P; Antel JP; Yong VW
    Ann Neurol; 1999 Sep; 46(3):319-24. PubMed ID: 10482262
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
    Yushchenko M; Mäder M; Elitok E; Bitsch A; Dressel A; Tumani H; Bogumil T; Kitze B; Poser S; Weber F
    J Neurol; 2003 Oct; 250(10):1224-8. PubMed ID: 14586607
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients.
    Comabella M; Imitola J; Weiner HL; Khoury SJ
    J Neuroimmunol; 2002 May; 126(1-2):205-12. PubMed ID: 12020972
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deep morphea after vaccination in two young children.
    Torrelo A; Suárez J; Colmenero I; Azorín D; Perera A; Zambrano A
    Pediatr Dermatol; 2006; 23(5):484-7. PubMed ID: 17014648
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.
    Arabi YM; Alothman A; Balkhy HH; Al-Dawood A; AlJohani S; Al Harbi S; Kojan S; Al Jeraisy M; Deeb AM; Assiri AM; Al-Hameed F; AlSaedi A; Mandourah Y; Almekhlafi GA; Sherbeeni NM; Elzein FE; Memon J; Taha Y; Almotairi A; Maghrabi KA; Qushmaq I; Al Bshabshe A; Kharaba A; Shalhoub S; Jose J; Fowler RA; Hayden FG; Hussein MA;
    Trials; 2018 Jan; 19(1):81. PubMed ID: 29382391
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients.
    Garcia-Montojo M; De Las Heras V; Dominguez-Mozo M; Bartolome M; Garcia-Martinez MA; Arroyo R; Alvarez-Lafuente R;
    Eur J Neurol; 2011 Aug; 18(8):1027-35. PubMed ID: 21518144
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Radiosensitizing effect of natural and recombinant beta-interferons in a human lung carcinoma in vitro.
    Schmidberger H; Rave-Fränk M; Lehmann J; Schweinfurth S; Pradier O; Hess CF
    J Cancer Res Clin Oncol; 1999; 125(6):350-6. PubMed ID: 10363567
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.
    Weber-Schoendorfer C; Schaefer C
    Mult Scler; 2009 Sep; 15(9):1037-42. PubMed ID: 19692433
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measured neutralizing titers of IFN-beta neutralizing antibodies (NAbs) can depend on the preparations of IFN-beta used in the assay.
    Files JG; Hargrove D; Delute L; Cantillon M
    J Interferon Cytokine Res; 2007 Aug; 27(8):637-42. PubMed ID: 17784815
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.
    Chan JF; Yao Y; Yeung ML; Deng W; Bao L; Jia L; Li F; Xiao C; Gao H; Yu P; Cai JP; Chu H; Zhou J; Chen H; Qin C; Yuen KY
    J Infect Dis; 2015 Dec; 212(12):1904-13. PubMed ID: 26198719
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiple cutaneous necrotic lesions associated with Interferon beta-1b injection for multiple sclerosis treatment: A case report and literature review.
    Faghihi G; Basiri A; Pourazizi M; Abtahi-Naeini B; Saffaei A
    J Res Pharm Pract; 2015; 4(2):99-103. PubMed ID: 25984549
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferon-beta therapy for multiple sclerosis--is the injection site the relevant action site?
    Smith D
    J Neuroimmunol; 2009 Oct; 215(1-2):117-21. PubMed ID: 19773087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical and experimental studies of multiple sclerosis in Russia: experience of the leading national research centers.
    Zavalishin IA; Belogurov AA; Lomakin YA; Ponomarenko NA; Morozova SN; Suslina ZA; Piradov MA; Illarioshkin SN; Gabibov AG
    Degener Neurol Neuromuscul Dis; 2015; 5():83-90. PubMed ID: 32669915
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interferon beta for multiple sclerosis.
    Connelly JF
    Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current and future disease-modifying therapies in multiple sclerosis.
    Lim SY; Constantinescu CS
    Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Classification of morphea (localized scleroderma).
    Peterson LS; Nelson AM; Su WP
    Mayo Clin Proc; 1995 Nov; 70(11):1068-76. PubMed ID: 7475336
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.
    Feng X; Bao R; Li L; Deisenhammer F; Arnason BGW; Reder AT
    EBioMedicine; 2019 Nov; 49():269-283. PubMed ID: 31648992
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
    Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
    Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of IFN-beta on human cerebral blood flow distribution.
    Mackowiak PA; Siegel E; Wasserman SS; Cameron E; Nessaiver MS; Bever CT
    J Interferon Cytokine Res; 1998 Jun; 18(6):393-7. PubMed ID: 9660246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.